Article citationsMore>>

Khan, Z., Khan, N., Tiwari, R.P., Patro, I.K., Prasad, G.B. and Bisen, P.S. (2010) Down-Regulation of Survivin by Oxaliplatin Diminishes Radioresistance of Head and Neck Squamous Carcinoma Cells. Radiotherapy and Oncology, 96, 267-273.
https://doi.org/10.1016/j.radonc.2010.06.005

has been cited by the following article:

• TITLE: A Review on Survivin as a Prognostic and Therapeutic Cancer Biomarker

  AUTHORS: Amal Ahmed Ismail

  KEYWORDS: Survivin, Prognostic Biomarker, Cancer, Antiapoptotic

  JOURNAL NAME: Open Journal of Pathology, Vol.8 No.1, December 29, 2017

  ABSTRACT: Survivin is an antiapoptotic protein expressed in tumor cells that correlates with aggressiveness, prognosis and treatment. Objective: This review summarizes significance of survivin expression among different tumor types highlighting the potential value of survivin as an important biomarker that may have an impact on patient’s response to therapy with prognostic implications.